Rebecca Hall

Rebecca Hall, PhD

Vice President, Strategy and Academic Affairs, Academic Institute
Houston Methodist


Rebecca Hall, PhD was appointed Vice President of Strategy and Academic Affairs in 2019. She provides oversight and guidance of strategic initiatives and partnerships for the Houston Methodist Academic Institute, which serves 750 faculty and 41,000 learners from 68 countries, and has an annual operating budget of $220 million and planned strategic initiatives powered by a $500 million capital campaign through 2030.  In this capacity she serves as advisor to the Chief Academic Officer of Houston Methodist in matters relating to research and education strategic planning and development, strategic initiative progress, faculty needs and national reputation.

Dr. Hall joined Houston Methodist in 2010 and has built and leads offices within the Institute including communications, faculty development, research development, planning, and institutional research.  Prior to joining Houston Methodist, she was an Assistant Professor of Cell and Molecular Biology for Baylor College of Medicine,  an Aspen Cancer Conference Fellow, and received the Theodore T. Puck Award for Cancer Research for her work on molecular cancer diagnostics. She has been a dedicated formal and informal mentor throughout her academic and administrative career.

Dr. Hall is a member of the AAMC and serves on the Group for Institutional Planning and the Group on Research Advancement and Development, the National Organization of Research Development Professionals. She is also a member of the Society for Healthcare Strategy & Development, and the American Association for the Advancement of Science. She serves on the external advisory board for the Center for Health and Nature, and tri-institutional consortium of Houston Methodist, Texas A&M University, and Texan by Nature to advance research health and nature to inform public health, public policy, and conservation strategies.

Dr. Hall graduated from Merrimack High School in NH where she was a national merit scholar, received her bachelor’s in Biochemistry from the University of Illinois at Urbana-Champaign where she studied abroad at the University of Queensland in Brisbane, and received her PhD degree in Immunology from Baylor College of Medicine.  

Areas Of Expertise

Research Development Communications Collaboration Strategic Planning
Education & Training

PhD, Baylor College of Medicine

A Portrait of Nanomedicine and Its Bioethical Implications
Hall, RM, Sun, T & Ferrari, M 2012, , Journal of Law, Medicine and Ethics, vol. 40, no. 4, pp. 763-779.

A framework for image-based classification of mitotic cells in asynchronous populations
Slattery, SD, Newberg, JY, Szafran, AT, Hall, R, Brinkley, BR & Mancini, MA 2012, , Assay and Drug Development Technologies, vol. 10, no. 2, pp. 161-178.

Aurora-C kinase supports mitotic progression in the absence of Aurora-B
Slattery, SD, Mancini, MA, Brinkley, BR & Hall, RM 2009, , Cell Cycle, vol. 8, no. 18, pp. 2986-2997.

Reprogramming of human somatic cells using human and animal oocytes
Chung, Y, Bishop, CE, Treff, NR, Walker, SJ, Sandler, VM, Becker, S, Klimanskaya, I, Wun, WS, Dunn, R, Hall, RM, Su, J, Lu, SJ, Maserati, M, Choi, YH, Scott, R, Atala, A, Dittman, R & Lanza, R 2009, , Cloning and Stem Cells, vol. 11, no. 2, pp. 213-223.

Aurora-C and Aurora-B share phosphorylation and regulation of CENP-A and Borealin during mitosis
Slattery, SD, Moore, RV, Brinkley, BR & Hall, R 2008, , Cell Cycle, vol. 7, no. 6, pp. 787-795.

Intracellular protein binding to asbestos induces aneuploidy in human lung fibroblasts
MacCorkle, R, Slattery, SD, Nash, DR & Brinkley, BR 2006, , Cell Motility and the Cytoskeleton, vol. 63, no. 10, pp. 646-657.

Mitogen-activated protein kinases in cell-cycle control
MacCorkle, R & Tan, TH 2005, , Cell biochemistry and biophysics, vol. 43, no. 3, pp. 451-461.

Inhibition of JNK2 disrupts anaphase and produces aneuploidy in mammalian cells
MacCorkle, R & Tan, TH 2004, , Journal of Biological Chemistry, vol. 279, no. 38, pp. 40112-40121.

Protein phosphatase 4 is involved in tumor necrosis factor-a-induced activation of c-Jun N-terminal kinase
Zhou, G, Mihindukulasuriya, KA, MacCorkle-Chosnek, R, Van Hooser, A, Hu, MCT, Brinkley, BR & Tan, TH 2002, , Journal of Biological Chemistry, vol. 277, no. 8, pp. 6391-6398.

A novel conditional Akt 'survival switch' reversibly protects cells from apoptosis
Li, B, Desai, SA, MacCorke-Hall, R, Fan, L & Spencer, DM 2002, , Gene Therapy, vol. 9, no. 4, pp. 233-244.

Cell cycle regulation of c-Jun N-terminal kinase activity at the centrosomes
MacCorkle-Chosnek, R, VanHooser, A, Goodrich, DW, Brinkley, BR & Tan, TH 2001, , Biochemical and Biophysical Research Communications, vol. 289, no. 1, pp. 173-180.

Synthetic activation of caspases: Artificial death switches
MacCorkle, RA, Freeman, KW & Spencer, DM 1998, , Proceedings of the National Academy of Sciences of the United States of America, vol. 95, no. 7, pp. 3655-3660.